Shimadzu Receives Vizient Contract for Cardiac and Vascular Interventional Systems and General Radiology Systems

Shimadzu Medical Systems USA, a leading manufacturer of advanced medical X-ray imaging systems, has announced that the Trinias unity edition product line has been awarded a contract from Vizient, Inc., the nation’s largest health care performance improvement company, effective September 1, 2021.

The agreement for Trinias unity edition product line, which consists of the Cardiac and Vascular Interventional digital angiography systems, offers enhanced savings to Vizient members.

The Trinias unity edition is available in several configurations with both Floor and Ceiling mounted C-Arms to meet both Cardiac and Vascular requirements with a range of flat panel detectors, including 8″,12″ and 16″ sizes. Bi-Plane configurations for 8″ and 12″ are also available for Cardiac and Neurology. “Shimadzu intraoperative x-ray systems have some unique features that improve both operator efficiency and workflow as well as patient comfort and safety,” says Tim Stevener, Shimadzu’s Director of the IXR product line. Stevener goes on to say, “exclusive features like reciprocal space mapping-digital angiography system provides incredible images even if the patient unexpectantly moves, while STENTVIEW, using artificial intelligence, allows the physician to visualize even the smallest wires and stents used.”

Shimadzu currently has general diagnostic X-ray imaging equipment on contract with Vizient and available for purchase, and has been awarded a new agreement for these products that is effective on Oct 1, 2021, offering the following systems:

  • RADspeed PRO radiographic systems series featuring POWERGLIDE
  • MobileDaRt MX8 DR mobiles with Canon or Konica FPD’s
  • SONIALVISION G4LX – Advanced Universal RF system
  • FLUOROspeed X1 – Patient-side RF Table System

Tom Kloetzly, Vice President of National Sales and Marketing states, “With the contract for the Trinias unity edition, Shimadzu’s complete X-ray product portfolio is available to Vizient members nationally at contracted pricing.”

Vizient is the largest member-driven performance improvement company in the country. Vizient’s diverse membership and customer base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers. Vizient membership represents more than $110 billion in annual purchasing volume.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."
Adrian Mendes, Perimeter's Chief Executive Officer, stated, "We believe this additional commercial placement within a major national healthcare system – representing the fifth unit placed with this existing customer network – demonstrates that surgeon end users, as well as other stakeholders within the broader healthcare system, see the value of our technology and are recommending it to their peers. Our aim is to make Perimeter's innovative technology the standard of care in cancer surgery."

By using this website you agree to accept Medical Device News Magazine Privacy Policy